GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Banner Health
- Study ID
- NCT02564692
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 90 Years
- Healthy Volunteers
- Accepted
Study Details
The purpose of the Alzheimer's Prevention Registry GeneMatch program is to identify a large group of people interested in participating in research studies or clinical trials based in part on their genetic background. This genetic information will be used to match interested individuals to studies, providing a recruitment resource to the Alzheimer's scientific community. Interested individuals should visit www.endALZnow.org/GeneMatch to join the GeneMatch program.
Key Dates
- Start date
- Nov 30, 2015
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 500,000 participants (estimated)
Primary Outcome Measure
Number of individuals who enroll in GeneMatch [ Time Frame: 15 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | - |
Find similar trials in Phoenix, AZ
By condition
By specialty
By research site
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's DiseaseEnrolling By Invitation · Banner Health · Phoenix, Arizona
- Arizona Alzheimer's Disease Research Center (ADRC)Recruiting · Banner Health · Phoenix, Arizona